Heart Failure 2021 and Beyond - Optimising Outcomes in Heart Failure

Objectives of the workshop

• Discuss and align challenges and opportunities facing the development of new medicines and technologies for heart failure.
• Identify hurdles in implementation and approaches to overcome them.
• Define what needs to be modified/changed/optimised in the development and implementation of the new guidelines.

Programme

View faculty biographies

DAY 1 – 16 September 2021 - 14:00-17:15 CEST

The evidence and the implementation of ESC Clinical Practice Guidelines

Chaired by Prof. E. Jankowska and Dr. T. Andersson

• 16 September

• 14:00-14:10 - Introduction: Goals of the CRT and objectives of the workshop by Dr. C. Kaiser-Albers

• SESSION 1 – ESC Clinical Practice Guidelines 2021 – Where do we stand and what evidence do we stand on?
  Moderated by Prof. E. Jankowska and Dr. T. Andersson

• 14:10-14:25 - Presentation of the new Guidelines by Prof. M. Metra (IT) and Prof. T. McDonagh (UK)

• 14:25-14:35 - The concept of a universal definition of heart failure: Why and what it means in practice (A joint venture of HFA/HFSA/JHFS societies) by Prof. B. Bozkurt (US)

• 14:35-14:55 - Reflections on the Guidelines and how they are Implemented: How well did we do in the last five years? Examples of Entresto and ICD/CRT by Prof. J. McMurray and Prof. W. Mullens (BE)

• 14:55-15:05 - How do we improve implementation of evidence in practice? Perspectives from outside western Europe by Dr. O. Chioncel (RO)

• 15:05-15:45 - Panel discussion including academia, industry, payers, regulatory, patients

• 15:45-16:00 - Break

• 16:00-17:00 - Breakout Sessions: Moderated by appointed experts and discussants
  Topic: Why is the uptake of life-saving treatments for heart failure still sub-optimal?

• 17:00-17:15 - Summary of pitches – Wrap-up Day 1 – Outlook on Day 2 by Prof. E. Jankowska and Dr. C. Kaiser-Albers

DAY 2 – 17 September 2021 - 14:00-17:30 CEST

Optimising outcomes in heart failure 

Chaired by Prof. J. McMurray and Dr. C. Kaiser-Albers

• 14:00-14:15 - Summary of Day 1 – Viewpoints from the Breakout Sessions, What else are the hot topics in heart failure? by Dr. C. Kaiser-Albers and Dr. T. Andersson
• SESSION 2 – Optimising outcomes in heart failure: what else? Moderated by Prof. J. Mc Murray and Dr. C. Kaiser-Albers
• 14:15-14:25 - What do we mean by “HFpEF” in 2021 and how should it be treated? by Prof. S. Solomon (US)
• 14:25-14:35 - Should we bother about the treatment advances: Quality of life and functional capacity? by Prof. A. Coats (UK)
• 14:35-14:45 - How do we measure QoL and assess functional capacity? by Dr. L. Hill (UK)
• 14:45-14:55 - Patient perspective: What matters to me? (Video interview with a patient)
• 14:55-15:05 - How can regulators and payers contribute to optimise outcomes? – The EMA perspective by Dr. C. Mittmann (DE)
• 15:05-15:15 - How can regulators and payers contribute to optimise outcomes? – A general perspective of payers by Prof. U. Siebert (AT)
• 15:15-15:45 - Panel / Moderated discussion with panelists and experts representing a geographical diversity
• 15:45-16:00 - Break
• SESSION 3 – Going digital – Will it shake everything up? Moderated by Prof. M. Cowie and Prof. A. Goncalves (Philips)
• 16:00-17:30 - Quick perspectives:
  • 16:00-16:10 - Will digital tools help patients manage their disease better? Lifestyle, treatment and awareness of disease fluctuations by Prof. M. Volterrani (IT)
  • 16:10-16:20 - Can we capture clinical status, activity levels and treatment adherence remotely? by Prof. F. Koehler (DE)
  • 16:20-16:30 - Education, implementation, adherence, monitoring and outcomes – The digital future of cardiology by Dr. R. Califf (US)
  • 16:30-16:40 - Digital clinical trials – Patient enrolment, monitoring and collection of follow-up data by Prof. L. Lund (SE)
  • 16:40-17:15 - Panel Discussion – Could we have a common digital platform to deliver routine care and conduct clinical trials?
  • 17:15-17:30 - Key take-home messages / Recommendations for preparation of the publication by Chairpersons